FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

787732000: Risankizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3776694016 Risankizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3776695015 Risankizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3776694016 Risankizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3776695015 Risankizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5593121000241115 risankizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5593121000241115 risankizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risankizumab Is a Substance with interleukin 23 receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab Has disposition Interleukin 23 receptor antagonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab Is a anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab Is a Immunosuppressant (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab Is a Monoclonal antibody false Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab Is a Monoclonal immunoglobulin G (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing risankizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Risankizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Risankizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Risankizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Risankizumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Risankizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only risankizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Risankizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely risankizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Risankizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely risankizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Risankizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Risankizumab 90.361 mg/mL solution for injection Has precise active ingredient True Risankizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Risankizumab 90.361 mg/mL solution for injection Has basis of strength substance (attribute) True Risankizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Risankizumab therapy (procedure) Direct substance True Risankizumab Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start